Projects

Disease Burden and Surveillance


 Sr.No                   
 Title of the Project                     
 Funding Agency/Sponsor                                                     

 Collaborator/Association, if Any            

 Principal Investigator            

 Study Duration             

 1. Establish serial sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in the general population, India

NIHR-RESPIRE unit, University of Edinburgh   

Translational Health Science and Technology Institute (Govt. of India) ,Xcyton Diagnostics Pvt Ltd

Dr. Sanjay Juvekar

Jan-2021-Ongoing

 2. Establishing sentinel sero-surveillance to monitor the trend of SARS-nCoV-2 infection transmission in the general population in rural Western India

Grand Challenges India- Biotechnology Industry Research Assistance Council (BIRAC)   

     -

Dr. Sanjay Juvekar

Jan-2021-Ongoing

 3. Evaluation of Immunological Parameters in Healthy Indian Adults

Yakult Honsha Co.Ltd   

Yakult Honsha Co.Ltd

Dr. Sanjay Juvekar

Jul 2019-Dec 2019

 4. Etiology of Childhood Pneumonia in India: an ICMR Task Force Study

Indian Council for Medical Research (ICMR)   

ICMR- National Institute of Epidemiology, Chennai ICMR- National Institute of Virology, Pune

Dr. Ashish Bavdekar

Mar 2018-Mar 2020

 5. NCD Risk Factor Surveillance II

KEMHRC (Departmental Project)   

     -

Uddhavi Chavan

Jan 2017-Jun 2017

 6. Nasopharyngeal pneumococcal carriage study in South Asian infants

The University of Edinburgh/Sanofi Pasteur   

Child Health Research Foundation, Dhaka, Bangladesh

Dr. Ashish Bavdekar, Dr. Sanjay Juvekar

May 2017-Jan 2019

 7. National surveillance system for enteric fever in India

Bill and Milinda Gates Foundation   

Christian Medcial College, Vellore

Dr. Ashish Bavdekar

Oct 2017-Mar 2019

 8. Rapid Situational analysis of Nutritional status of Tribal Children under 5 years of age in Tribal dominant blocks of Palghar District to help develop evidence-based integrated (multiple sectorial) community actions to overcome malnutrition in this tribal population.

Departmental Study (on request from the ADHS, Govt of Maharashtra)   

Public Health System, Govt. of Maharashtra

Dr. Sanjay Juvekar

Nov 2016-Dec 2016

 9. Disease burden of hospitalised dengue in Vadu area in Western India

ICMR-National Institute of Virology, Pune   

ICMR-National Institute of Virology, Pune

Dr. Sanjay Juvekar

Jan 2014-Mar 2015

 10. Study of Phenotypic characterization (Using HRCT) of smoking and non-smoking COPD in a rural setting in India.

Imperial College London   

Chest Research Foundation, Pune and Imperial College London

Dr. Sanjay Juvekar, Dr. Dayanand Shetty

Aug 2013-May 2014

 11. Pnumonia Etiology Study

Foundation Muriex   

     -

Dr. Ashish Bavdekar

Jun 2012-Jun 2013

 12. Developing capacity for Tuberculosis Surveillance in Health and Demographic Surveillance Systems

KEMHRC (Departmental Project)   

 nbsp;nbsp;nbsp;nbsp;-

Dr. Sanjay Juvekar

Jan 2010- Jan 2011

 13. Influenza disease burden in rural communities in India

Centre for Disease Control Atlanta   

Indian Council for Medical Research

Dr. Sanjay Juvekar

Sep 2010-Aug 2013

 14. Ayurgenomics Integration of Ayurveda with Genomics: a novel approach in systems biology for predictive medicine

Council for Scientific and Industrial Research India    

CSIR-Institute of Genomics and Integrative Biology

Dr. Sanjay Juvekar

Apr 2009-Oct 2010

 15. Gut microflora in Children -A Pilot Study

KEMHRC (Departmental Project)   

National Centre for Cell Sciences

Dr. Ashish Bavdekar

Apr 2009-Oct 2010

 16. IMVAC 2

Imperial College London   

     -

Dr. Ashish Bavdekar

Jan 2008-Jan 2010

 17. Study of prevalence of copd and phenotypic characterization of smoking and non- smoking copd in a rurual setting in India (IMVAC)

Imperial College London   

Chest Research Foundation, Pune and Imperial College London

Dr. Siddhivinayak Hirve, Dr. Sanjay Juvekar

Mar 2008-Jul 2009

 18. Women, WASH and Health in Rural Pune District: Identifying stress and unmet needs.

London School of Hygiene and tropical Medicine.   

Swiss Tropical and Public Health Institue, Basel, Swizerland

Dr. Sanjay Juvekar

Mar 2008-Jul 2010

 19. Pune Microbiome Study

Department of Biotechnology (Govt. of India)   

National Centre for Cell Sciences

Dr. Sanjay Juvekar

Aug 2006-Jan 2010

 20. Study on global ageing (SAGE)

World Health Organization   

INDEPTH NETWORK, Accra, Ghana

Dr. Siddhivinayak Hirve

Jun 2005-Jun 2007

 21. Health Equity

INDEPTH NETWORK, Accra, Ghana   

INDEPTH NETWORK, Accra, Ghana

Dr. Sanjay Juvekar

Jun 2005-Jun 2006

 22. Handwashing Compliance and Risk of Acute Respiratory infections

London School of Hygine and tropical Medicine, UK   

The Hygiene Centre, London School of Hygiene & Tropical Medcine

Dr. Siddhivinayak Hirve

Jun 2004-Jun2005

 23. Non-Communicable Diseases Risk Factor Survillence in INDEPTH-Network Asia/Oceania sites

INDEPTH NETWORK, Accra, Ghana   

INDEPTH sites from Bangladesh, Indonesia, Vietnam and Thailand

Dr. Sanjay Juvekar

Feb 2004 - Jun 2005

 24. Vadu Health and Demographic Surveillance System

KEMHRC (Departmental Project)   

     -

Dr. Sanjay Juvekar

2002 - Ongoing

 

Vaccine Trials


 Sr.No                   
 Title of the Project                     
 Funding Agency/Sponsor                                                     

 Collaborator/Association, if Any            

 Principal Investigator            

 Study Duration           

 1. Phase III, randomized, open-label, multicentre study evaluating the immunogenicity and safety of Shan6 vaccine administered. Concomitantly with or without Measles-Mumps-Rubella (MMR vaccine), to healthy toddlers in India

Shantha Biotchincs Pvt Ltd    

     -

Dr. Anand Kawade

Aug-2020-Ongoing

 2. A phase II/III, observer-blind,randomized, active controlled study to determine the safety and immunogenecity of COVISHIELD(COVID-19 Vaccine)in healthy Indian adults

Serum Institute Of India Private Limited (SIIPL) Indian Council Of Medical Research (ICMR)    

National Institute of Virolog ,Pune

Dr. Ashish Bavdekar

Aug-2020-Ongoing

 3. A Phase 3, Randomized, Observer-blind, Controlled, Multi-Center Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine (NmCV-5) and to Compare its Safety and Immunogenicity with that of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age

Serum Institute Of India Private Limited (SIIPL)   

     -

Dr. Anand Kawade

Jan-2020-Ongoing

 4. Immune Lot-to-Lot Consistency and Non-Inferiority of SHAN6™ Vaccine in Comparison to SHAN 5® + SHANIPV™ When Administered as Three Doses at 6-8, 10-12 and 14-16 Weeks of Age in Healthy Indian Infants, Concomitantly with Oral Rotavirus Vaccine

Shantha Biotchincs Pvt Ltd   

     -

Dr. Anand Kawade

Feb 2019-Nov 2019

 5. Immunogenicity and Safety of Rotavac® and Rotasiil® Administered in an Interchangeable Dosing Schedule among Healthy Indian Infants: A Multicentric, Phase IV, Open Labeled, Randomized, Controlled Trial

ICMR- National Institute of Cholera & Enteric Disease (NICED), Kolkata    

National Insititue of Epidemiology (NIE), Chennai

Dr. Ashish Bavdekar

Mar 2019-Mar2020

 6. “A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, Immunogenicity and Non-Interference with Concomitant Vaccinations of Serum Institute of India’s 10-Valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) in Healthy Indian Infants”

Serum Institute Of India Private Limited    

     -

Dr. Ashish Bavdekar

Apr 2019-Oct 2019

 7. “A Phase 3, Randomized, Double-blind study to evaluate the immunogenicity, Safety and Tolerability of Serum Institute of India’s 10-Valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) in Healthy Indian Infants.”

Serum Institute Of India Private Limited    

     -

Dr. Ashish Bavdekar

Nov 2019-Nov 2020

 8. An open label, randomized, active controlled, multi-centric Phase II/III, study in Indian toddlers and infants to assess the immunogenicity and safety of SIIPL HEXASIIL™ (DTwP-HepB-IPV-Hib) Vaccine in comparison with SIIPL PENTAVAC (DTwP-HepB-Hib) + Poliovac (IPV) administered as separate injections.

Serum Institute Of India Private Limited    

     -

Dr. Anand Kawade

Dec 2019 to Jan 2020

 9. An open label, randomized, active-controlled, multi-centric phase-ii/iii study in indian toddlers and infants to assess the immunogenicity and safety of siipl hexasiiltm (dtwp-hepb-ipv-hib) vaccine in comparison with siipl pentavac (dtwp-hepb-hib) + poliovac (ipv) vaccines, administered as separate injections.

Serum Institute Of India Private Limited (SIIPL)    

     -

Dr. Anand Kawade

Dec-2019-Ongoing

 10. A Multicenter Phase II/III Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of VPM1002 in the Prevention of Tuberculosis (TB) Recurrence in Pulmonary TB Patients after Successful TB Treatment

Serum Institute Of India Private Limited (SIIPL)    

     -

Dr. Pradeep D'Costa

Jun-2018-Ongoing

 11. A Phase-II/III, Partially Double-blind, Randomized, Active-controlled, Multicentric Study to Assess the Immunogenicity and Safety of SIIPL’s qHPV Vaccine Administered Intramuscularly in Healthy Volunteers According to a Two-dose Schedule to Cohort 1 (Girls and Boys Aged 9-14 years) and a Three-dose Schedule to Cohort 2 (Women and Men Aged 15-26 years) as Compared to Merck’s HPV6/11/16/18 vaccine (Gardasil®).

Serum Institute Of India Private Limited (SIIPL)    

     -

Dr. Anand Kawade

Sep-2018-Ongoing

 12. A Phase II/III, Multicenter, Randomized, Open Lable, Active Controlled, Clinical Study to Assess the Immunogenicity and Safety of Tetanus Toxoid, Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine Manufactured by Serum Institute of India Pvt. Ltd (SIIPL) in comparison with Boostrix® Vaccine of GSK in Healthy Adults, Adolescents and Children in India. - Tdap

 Serum Institute Of India Private Limited (SIIPL)    

     -

Dr. Anand Kawade

Oct 2018- Jun 2020

 13. A phase ii/iii, multicenter, open-label, randomized study of liquid bovine rotavirus pentavalent vaccine (lbrv-pv) to evaluate lot-to-lot consistency and to compare non-inferiority with rotasiil (lyophilized brv-pv) in healthy infants in india

PATH & Serum Institute Of India Private Limited    

     -

Dr. Anand Kawade

Oct 2017- Oct 2018

 14. Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional dose IPV in routine immunization in post tOPV-bOPV period.

WHO & Panacea Biotech    

     -

Dr. Ashish Bavdekar

Jul 2017-Dec 2017

 15. "A Phase III, Multicenter, Open Label, randomized study of Bovine Rotavirus Pentavalent Vaccine (BRV-PV) to evaluate lot-to-lot consistency and to Investigate potential interference with routine UIP vaccinations in healthy infants in India".

PATH & Serum Institute Of India Private Limited    

     -

Dr. Anand Kawade

Jan 2016-Apr 2017

 16. Nasopharyngeal pneumococcal carriage and immunogenicity with reduced and alternate dose schedule of pneumococcal conjugate vaccine in infancy.

Bill and Milinda Gates Foundation/ INCLEN    

UCL Institute of Child Health (UCL ICH) University College London, UK Soroka University Medical Center, Israel Christian Medical College, Vellore Child Health Research Foundation, Dhaka, Bangladesh

Dr. Ashish Bavdekar

Jul 2016-Feb 2020

 17. A phase iv, non-inferiority, observer blind, randomized clinical study comparing safety and immunogenicity of measles-mumps-rubella (MMR) subcutaneous vaccination by disposable-syringe jet injector to vaccination by needle and syringe for the administration in healthy children in india aged 15 to 18 months

Pharmajet USA & Serum Institute Of India Private Limited    

     -

Dr. Ashish Bavdekar

Sep 2015-Nov 2015

 18. A phase III observer-blind, randomised, multicountry non influenza vaccine comparator controlled study to demonstrate the efficacy of GlaxoSmithkline Biologicals quadrivalent seasonal influenza candidate vaccine GSK2321138A(FLU d-QIV) administered intramuscularly in children 6-35 months of the age.

GSK Biological   

     -

Dr. Ashish Bavdekar

Apr 2014-Jan 2015

 19. Phase-III, multicenter, randomized, double-blind placebo-controlled study to evaluate the efficacy and safety of live attenuated bovine-human rotavirus pentavalent vaccine (BRV-PV) against severe rotavirus gastroenteritis in healthy Indian infants.

PATH & Serum Institute Of India Private Limited    

     -

Dr. Anand Kawade

Jun 2014-Jul 2017

 20. A phase III randomised double blind placebo controlled trial to evaluate the protective efficacy of three doses of oral rotavirus vaccine (ORV) 116E, against severe rotavirus gastroenteritis in infants.

Department of Biotechnology (Govt. of India), Bharat Biotech, & PATH    

     -

Dr. Ashish Bavdekar

Apr 2011-Nov 2013

 21. A phase 2a,Randomized,Controlled,Observer Blind ,Age De-Escalation,Multinational Study of Safty,Reactogenecity and Immunogenicity of the NVGH Glycoconjugate Vaccine against S.Typhi in Adults,Children,Older Infants and Infants

Novartis India   

     -

Dr. Ashish Bavdekar

Nov 2011-Jan 2012

 22. Pivotal study to evaluate the immunogenicity and safety of a measles vaccine given by aerosolised inhalation: randomized controlled trial

World Health Orgnization & Serum Institute Of India Private Limited    

     -

Dr. Siddhivinayak Hirve, Dr. Ashish Bavadekar

Sep 2009-Aug 2011

 23. A phase III double blind ranomized active controlled study to evalute the safety and consistency of immunogenicityof three consecutive lots of a menigoccoal a conjugate vaccine admin.as a single dose to healthy children 5-10yrs

PATH & Serum Institute Of India Private Limited   

     -

Dr. Siddhivinayak Hirve, Dr. Ashish Bavadekar

Dec 2009-Dec 2010

 24. A phase IV, open label comparative, comparative, parallel group, clinical study to evaluate the safety and immunogencity of Haemophilus influenzae Type-B vaccine (SII Hib PRO) of serum institute of India limited in indian infants

Serum Institute Of India Private Limited   

     -

Dr. Siddhivinayak Hirve

Jan 2008-Jan 2010

 25. A Phase II/III, observer-blind,randomized, active controlled study to compare the safety and immunogenicity of a meingococcal a conjugate vaccine (PsATT) with menigococcal ACYW polysaccharide vaccine administered in health children 2-10 years of age.

PATH & Serum Institute Of India Private Limited    

WHO

Dr. Siddhivinayak Hirve, Dr. Ashish Bavadekar

Jul 2007-Dec 2008

 

Implementation Research


 Sr.No                   
 Title of the Project                     
 Funding Agency/Sponsor                                                     

 Collaborator/Association, if Any            

 Principal Investigator            

 Study Duration            

 1. Assessment of feasibility of introducing pulse oximetry in IMNCI services in primary health facilities in Pune district

RESPIRE, University of Edinburgh    

Health Department, Zilla Parishad, Pune

Dr. Ashish Bavdekar

Nov 2019-Ongoing

 2. Formulating and testing a strategy for introducing Pulmonary Rehabilitation (PR) for COPD management in a rural Indian setting

RESPIRE, University of Edinburgh    

Depts. Of Pulmonolgy and Physiotherapy, KEM Hospital Pune

Dr. Sanjay Juvekar

Nov 2019-Ongoing

 3. Implementation research on a government health program for management of high-risk pregnancies in tribal communities in Pune district: barriers, facilitators and scalability

Alliance for Health Policy and Systems Research (HPSR) of the World Health Organization (WHO)   

Directorate of Health Services, Maharashtra State

Dr. Sanjay Juvekar

Aug 2019-Ongoing

 4. Testing the feasibility of integrated approaches to interrupt the transmission of soil transmitted helminths(STH) - the Deworm 3 Project

Natural History Museum UK    

Christian Medical College, Vellore

Dr. Sanjay Juvekar

Apr 2018-Aug 2020

 5. Enhancing LPG use during Pregnancy

NIH- Implementation Science Network    

University of California, Berkley

Dr. Sanjay Juvekar

Jun 2016-Jun 2019

 6. An innovative approach to jump start simplified management of sick young infants with Possible Serious bacterial Infection (PSBI) where referral is not possible for potential scale-up

World Health Organization    

Health Department, Zilla Parishad, Pune

Dr. Ashish Bavdekar

Aug 2016-Jul 2016

 7. Early Implementation of Rollout of Rotavirus Vaccine in the Public Health System Under Monitoring

Bill and Milinda Gates Foundation    

Directorate of Health Services, Maharashtra State CHRD- Society of Applied Studies, New Delhi Christian Medical College, Vellore

Dr. Ashish Bavdekar

Jan 2015-Jan 2019

 

Health Technology


 Sr.No                   
 Title of the Project                     
 Funding Agency/Sponsor                                                     

 Collaborator/Association, if Any            

 Principal Investigator            

 Study Duration           

 1. Establishing a microhealth centre at Pabal village to support the primary health using teleconsultation

Hewlett Packard and CSIR-Institute of Genomics and Integrative Biology   

CSIR-Institute of Genomics and Integrative Biology

Dr.Sanjay Juvekar

Apr 2015-Ongoing

 2. Strengthening Immunization services in Pune district

Science & Technology Park, Pune University   

Science & Technology Park, Pune University

Dr. Sanjay Juvekar

Jun 2015- Jun 2016

 3. Web GIS application for HDSS Using an Open Source Software

INDEPTH Network   

INDEPTH

Veena Muralidharan

Mar 2011-Oct 2011

 4. INTREC (INDEPTH Training and Research Centres of Excellence) project

INDEPTH   

     -

Dr. Sanjay Juvekar

Apr 2011-Mar 2013

 5. Developing a public health informatics platform in India for a system view of health and diseases

Department of Science and Technology   

CSIR-Institute of Genomics and Integrative Biology

Dr. Sanjay Juvekar, Dr. C. Yajnik

Jan 2010- Ongoing

 6. INDEPTH Stats

INDEPTH Network   

INDEPTH Network

Dr. Sanjay Juvekar, Somnath Sambhudas

Jun 2010- Nov 2010

 7. INDEPTH Data Sharing Project Grant No.IND/CS004a/2009 Extending & Expanding Capacity in HDSS Data Sharing among 3 African HDSS Sites in Synchronization with the Existing Data Sharing Platform among 3 Asian HDSS Sites

INDEPTH NETWORK, Accra, Ghana (from Hewlett Foundation funds)   

Agincourt HDSS (South Africa), Dickgale (South Africa) and Magu HDSS (Tanzania)

Dr. Sanjay Juvekar

Feb 2009- Ongoing

 8. Developing a prototype for data sharing building capacity in data management across India, Thailand and Papua New Guinea

INDEPTH NETWORK, Accra, Ghana (from Swidish International Development Agency- SIDA funds)   

Wosera HDSS (Papua New Guinea), Kanchanaburi HDSS (Thailand)

Dr. Sanjay Juvekar

Jun 2005- Ongoing

 

Social and Behavioral Research


 Sr.No                   
 Title of the Project                     
 Funding Agency/Sponsor                                                     

 Collaborator/Association, if Any            

 Principal Investigator            

 Study Duration             

 1. International surveillance study of movements behaviors in the early years.

KEMHRC (Departmental Project)    

 University of Wollongong, Australia

Ms. Himangi Lubree

Jan-2020-Ongoing

 2. Social drivers of acceptance and rejection of protective measures against COVID-19 infection in the community

KEMHRC (Departmental Project)    

     -

Dr. Sanjay Juvekar

May 2020-July 2020

 3. Assessment of ASHA’S work load and its determinants

Respire, University of Edinburgh   

     -

Dr. Anand Kawade

Jan 2019-Mar 2020

 4. Prepardness of Marriage

Indian Council for Medical Research (ICMR)    

     -

Dr. Sanjay Juvekar

Jan 2012-Jan 2014

 5. Socio Economic status Assesment of Population for understanding health Equity in HDSS VADU Area

INDEPTH    

INDEPTH NETWORK,Accra

Dr. Sanjay Juvekar

Jun 2005-Jun 2006

 

Other Intervention


 Sr.No                   
 Title of the Project                     
 Funding Agency/Sponsor                                                     

 Collaborator/Association, if Any            

 Principal Investigator            

 Study Duration            

 1. A randomised study to evaluate effect of nano-encapsulated micronutrient fortified body oils for infant massage on developmental and nutritional outcomes

Grand Challenges Canada   

Indian Institute of Technology Bombay, Mumbai

Dr. Ashish Bavdekar, Dr.Aditi Apte

Dec 2017-Dec 2019

 2. Effectiveness of bovine colostrum in treatment of influenza like illness in paediatric patients

Biostrum Nutritech Pvt. Ltd   

     -

Dr. Anand Kawade

May 2016-Jul 2016

 3. Testing adoption of improved cookstoves in rural India after targetted behaviour intervention

John Hopkins University Bloomberg School of Public Health, Baltimore, USA   

Chest Research Foundation, Pune

Dr. Sandeep Salve, Dr. Ashish Bavdekar

Apr 2013-Sep 2013

 4. Cookstove Study

Council for Scientific and Industrial Research India and John Hopkins University   

Institute of Genomics and Integrative Biology and Chest Research Foundation, Pune

Dr. Sanjay Juvekar

Apr 2013-Sep2013

 5. The study of feasibility and effectiveness of conducting a community survey using mobile-phone based technology to study the prevalence of airways obstruction amongst pesticide sprayers.

KEMHRC (Departmental Project)    

IGIB-CSIR Delhi, Govt.of India and Chest Reseach Foundation, Pune

Dr. Sanjay Juvekar

Sep 2013-Aug 2014

 6. Survillance for Prevention of Anemia in Children under 5- ICDS administration of low dose Sprinkles (Sprinkles II)

Hellen Keller,Heinz    

ICDS, Government of Maharashtra

Dr. Siddhivinayak Hirve, Dr. Sanjay Juvekar

Apr 2009 - Mar 2010

 7. Suppliment of the Iron atta study primarily supported by the DBT , Govt. Of India

Akzo Noble and Department of Biotechnology, Gov. of India, New Delhi and Akzo Nobel    

Department of Biotechnology

Dr. Siddhivinayak Hirve

Jul 2007-Sep 2008

 8. Survillance for Prevention of Anemia in Children under 5 years- administration of low dose Sprinkles (Sprinkles I)

Hospital for Sick Kids, Toronto    

     -

Dr. Anand Pandit, Dr. Siddhivinayak Hirve, Dr. Ashish Bavdekar

Jun 2004 -Jun 2006

 
 

Contact Us
eg. (Mark Calcara)
eg. (yourname@domain.com)
Reach Us
BilerChildrenLeg og SpilAutobranchen